FDA.reportPublic FDA data

adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]

RxCUI
2668204
RxNorm name
adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]
Display name
adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]
Full name
adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:09

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CabtreoCLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENEBausch Health US LLC9468da0f-9978-4c58-8135-0274c34150842025-04-24Warnings, Adverse reactionsExact identifier
rxcui: 2668204

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
9468da0f-9978-4c58-8135-0274c3415084CABTREO 1.2 % / 0.15 % / 3.1 % Topical Gel [PSN] · adapalene 0.0015 MG/MG / benzoyl peroxide 0.031 MG/MG / clindamycin phosphate 0.012 MG/MG Topical Gel [Cabtreo] [SBD] · Cabtreo (adapalene 0.15 % / benzoyl peroxide 3.1 % / clindamycin phosphate 1.2 % ) Topical Gel [SY]36These highlights do not include all the information needed to use CABTREO safely and effectively. See full prescribing information for CABTREO. CABTREO ® (clindamycin phosphate, adapalene, and benzoyl peroxide) topical gel Initial U.S. Approval: 202320250424